PS
NRIX icon

Peter Svennilson’s Nurix Therapeutics NRIX Stock Holding History

Peter Svennilson’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$236M Buy
+6,755,881
New +$170M 19.24% 3

Other funds holding NRIX

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Peter Svennilson's NRIX Position: Q3 2020 in Review

Peter Svennilson opened a new position in Nurix Therapeutics (NRIX) in Q3 2020: 6,755,881 shares worth $236M. The stake represents 19.24% of the portfolio and ranks #3 among its holdings.

66 funds tracked by Wall St. Rank hold NRIX as of Q3 2020.

  • Peter Svennilson held 6,755,881 shares of Nurix Therapeutics worth $236M as of Q3 2020.
  • Nurix Therapeutics was a new Peter Svennilson position in Q3 2020.
  • Nurix Therapeutics made up 19.24% of Peter Svennilson's portfolio in Q3 2020, its #3 holding.
  • 66 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2020.

Based on Peter Svennilson's 13F filing for Q3 2020, filed 4 Nov 2020.